BioCentury
ARTICLE | Clinical News

DHEA data

January 15, 1996 8:00 AM UTC

Positive results of a double-blind, placebo-controlled, randomized Phase II trial in 28 women with mild to moderate SLE were published in Arthritis and Rheumatism.

Patients on placebo neither improved nor reduced doses of the steroid (p=0.022). Lupus flares occurred more frequently in the placebo group (p=0.053). ...